4584 — Kidswell Bio Balance Sheet
0.000.00%
- ¥5bn
- ¥6bn
- ¥2bn
- 13
- 13
- 62
- 15
Annual balance sheet for Kidswell Bio, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 2,033 | 1,461 | 1,187 | 1,067 | 2,231 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 652 | 817 | 462 | 1,089 | 881 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 3,322 | 3,346 | 3,326 | 3,697 | 4,924 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.98 | 3.22 | 1.64 | 1.48 | 1.32 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 3,592 | 3,934 | 3,503 | 3,895 | 5,086 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 881 | 1,114 | 1,129 | 1,056 | 2,375 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,105 | 2,324 | 1,785 | 2,661 | 4,254 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 1,487 | 1,610 | 1,719 | 1,234 | 831 |
Total Liabilities & Shareholders' Equity | 3,592 | 3,934 | 3,503 | 3,895 | 5,086 |
Total Common Shares Outstanding |